Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIVALIRUDIN vs BOCEPREVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIVALIRUDIN vs BOCEPREVIR: Safety Overview

Metric BIVALIRUDIN BOCEPREVIR
Total FAERS Reports 839 2,078
Deaths Reported 137 112
Death Rate 16.3% 5.4%
Hospitalizations 249 478
Average Patient Age 53.2 yrs 53.1 yrs
% Female Patients 33.7% 44.4%
FDA Approval Date Dec 15, 2000 May 13, 2011
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued